Testing brain blood vessel response to carbon dioxide in children with sickle cell
Uses brain MRI and breathing carbon dioxide in children with sickle cell disease.
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- St Louis, United StatesSee the site
- Trial code
- Registry title
- Cerebral Oxygen Metabolism in Children
- Status
- Recruiting
- People taking part
- 350 people, planned
- Started
- 17 Oct 2019
- Expected to end
- Dec 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Carbon Dioxide
- Record updated
- 11 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy people, people with sickle cell anemia, and people who had ECMO treatment in the past. They must be able to have an MRI scan without sedation.
- Age
- 3 to 50 years
- Sex
- All sexes can join.
- Disease stage
- Sickle cell group: Hb SS or SBeta-thal. ECMO group: history of cannulation for ECMO. Healthy group: no stroke or cerebrovascular disease history.
- Earlier treatment
- ECMO group: must have had cannulation for ECMO. All groups: not on vasodilatory medication such as sildenafil or verapamil. Healthy group: not taking a daily preventative medication for headaches.
- Biomarker or test result
- Sickle cell group: Hb SS or SBeta-thal.
Main reasons for not taking part
- Currently pregnant
- Cannot have an MRI scan without sedation
- Taking vasodilatory medication such as sildenafil or verapamil
- Healthy group: history of epilepsy
- Healthy group: history of stroke or cerebrovascular disease
The registry criteria, word for word
Show all 19 criteriaShow less
Other criteria
- Healthy Controls:
- Healthy controls ages 3-50 years of age
- Able to participate in MRI scan without sedation
- Not currently pregnant
- No significant psychiatric history, defined as having a severe psychiatric diagnosis, per PI discretion
- No history of epilepsy
- No history of stroke or cerebrovascular disease
- May have occasional headaches if not taking a daily preventative medication for headaches
- Not on vasodilatory medication, such as sildenafil or verapamil; Sickle Cell Anemia Participants:
- Ages 3-50 years of age
- Hb SS or SBeta-thal
- Able to participate in MRI scan without sedation
- Not currently pregnant
- Not on vasodilatory medication, such as sildenafil or verapamil; Extracorporeal Membrane Oxygenation (ECMO) Survivors:
- Ages 3-50 years of age
- History of cannulation for ECMO
- Able to participate in MRI scan without sedation
- Not currently pregnant
- Not on vasodilatory medication, such as sildenafil or verapamil
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 50 years old?
Where in United States
- Washington University of St. LouisSt Louis, United StatesContact: Kristin Guilliams, MDTaking people
About the trial
What the trial wants to find out
The purpose of this research study is to better understand how blood flow and metabolism change can influence brain development in the early decades of life.
Read full original descriptionShow less
We will examine brain blood flow and metabolism using magnetic resonance imaging (MRI). The brain's blood vessels expand and constrict to regulate blood flow based on the brain's needs. The amount of expanding and contracting the blood vessels can do varies by age. The brain's blood flow changes in small ways during everyday activities, such as normal brain growth, exercise, or deep concentration. Significant illness or psychological stress may increase the brain's metabolic demand or cause other bigger changes in blood flow. If blood vessels are not able to expand to give more blood flow when metabolic demand is high, the brain may not get all of the oxygen it needs. In extreme circumstances, if the brain is unable to get enough oxygen for a long time, a stroke may occur. Sometimes small strokes occur without other noticeable changes and are only detectable on an MRI. These are sometimes called "silent strokes." In less extreme circumstances, not having as much oxygen as it wants may cause the brain to grow and develop more slowly than it should.
One way to test the ability of blood vessels to expand is by measuring blood flow while breathing in carbon dioxide. Carbon dioxide causes blood vessels in the brain to dilate without increasing brain metabolism.
During this study participants may be asked to undergo a blood draw, MRI, and potential neuropsychological assessments. It is also possible that the study team will use a special mask to control the amount of carbon dioxide the participants breathe in so they don't breathe in too much.
The 3 groups in the trial
- Healthy ControlsExisting treatment, for comparison
Treatment: Carbon Dioxide
- Extracorporeal Membrane Oxygenation survivorsExisting treatment, for comparison
Treatment: Carbon Dioxide
- Sickle Cell Anemia participantsExisting treatment, for comparison
Treatment: Carbon Dioxide
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Cerebral Oxygen Metabolism in Children
- Plain-language title
- Testing brain blood vessel response to carbon dioxide in children with sickle cellGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04157179, who can take part
- Record updated
- 11 September 2025